OBS MEDICAL
About OBS MEDICAL
OBS Medical, a spin-out from Oxford University established in 2000, is a healthcare AI company dedicated to enhancing patient safety and optimizing healthcare delivery through advanced predictive analytics and clinical decision support software (CDSS). The company’s core mission is to provide medical professionals with clear, actionable insights for patient risk stratification and early alerts, ultimately aiming to save lives and reduce healthcare costs. Their flagship product, Visensia – The Safety Index, utilizes proprietary algorithms to analyze and interpret patterns from vital signs collected via bedside monitors and ambulatory devices. This generates a single, intuitive early-warning index, facilitating the proactive detection of patient deterioration across various care settings, including emergency, critical care, general wards, and remote home monitoring for chronic conditions such as diabetes, COPD, and hypertension.
Beyond Visensia, OBS Medical’s portfolio includes BioQT Cardiac Safety with Confidence, an automated ECG software tool designed for precise QT prolongation measurement. The company has also expanded its offerings through strategic partnerships, notably with Therapeutic Monitoring Systems Inc., to develop specialized predictive analytics. This collaboration has yielded the Extubation Advisor (EA), a crucial bedside decision support tool that predicts extubation outcomes and standardizes readiness assessments for critically ill patients in intensive care units. OBS Medical’s technology emphasizes interoperability, integrating clinical data from existing patient monitoring infrastructures with modern wearable and sensor technologies to present a comprehensive view on a unified clinical dashboard. The company maintains a strong commitment to quality, holding ISO 13485 certification, with Visensia being both FDA cleared and CE Marked.
Focus Areas
Business Intelligence
| Key Investors | Vodafone, Lionel Tarassenko, Spark Ventures |
| Partnerships | Therapeutic Monitoring Systems Inc (TMS), Nihon Kohden, Qardio, Excel Medical (now Hillrom) |
| Acquisitions | T+ Medical (2010) |
| Technology | Visensia Interoperability and Analytics Platform, data fusion technology, predictive algorithms, intelligent monitoring algorithm, real-time analytics |
| FDA Clearances | 4 cleared products (estimated) |
What Physicians Need to Know
For physicians, OBS MEDICAL's Visensiau00ae offers a powerful tool to enhance patient safety and optimize clinical workflow. The system provides an objective, unambiguous 'Safety Index' that simplifies complex physiological data into an actionable score, aiding in early intervention and communication among care teams. This leads to a significant reduction in unexpected deaths, 'code blue' events, and length of hospital stay. Its high sensitivity and specificity (95% true alerts) help combat alarm fatigue, allowing clinicians to trust and respond more effectively to critical alerts. Furthermore, the ability to integrate with existing monitoring infrastructure and support remote patient monitoring extends its utility across various care settings, from acute care to out-of-hospital environments. This allows for better prioritization of nursing resources and more informed decisions regarding patient transfers and discharge.
OBS MEDICAL's Visensiau00ae is designed for broad interoperability, offering a standard Health Level 7 (HL7) interface for communication with other data acquisition systems. This allows healthcare organizations to leverage their existing patient monitoring infrastructure. The Visensia Interoperability and Analytics Platform also combines data from legacy systems with the latest wearable and sensor technology, making it vendor and device agnostic. They have established partnerships with companies like Qardio (for QardioMD+VSI remote monitoring) and Therapeutic Monitoring Systems Inc. (for a suite of predictive analytics including Extubation Advisor), demonstrating their commitment to a comprehensive and integrated approach to patient monitoring.
Reviews & Opinions
Videos
News, demos, and interviews about OBS MEDICAL.
Videos load interactively. If none appear, search YouTube for OBS MEDICAL →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded OBS MEDICAL.
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]